9 products suspended from health insurance benefits for provision of approx. KRW 2.6 billion rebates

Published: 2017-05-02 13:58:26

Updated: 2017-05-02 13:58:26

Novartis’ 9 rebated drugs will be suspended from the health insurance benefits.

When it came to Novartis Korea’s issue about provision of rebates, the Ministry of Health and Welfare(MOHW) announced on the 27^th that it suspended the health insurance benefits of 9 products, such as Exelon Cap & Patch and Zometa Inj, for 6 months and impose the total KRW 55.1 billion fines on the rest 33 products...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.